195 related articles for article (PubMed ID: 18187888)
1. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
Altaf M; Miller CH; Bellows DS; O'Toole R
Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
[TBL] [Abstract][Full Text] [Related]
6. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK.
Melzer M; Gupta N; Petersen I; Cook S; Hall B
Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460
[TBL] [Abstract][Full Text] [Related]
7. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
8. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
Sagar T; Singh NP; Kashyap B; Kaur IR
J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.
Shiferaw G; Woldeamanuel Y; Gebeyehu M; Girmachew F; Demessie D; Lemma E
J Clin Microbiol; 2007 Apr; 45(4):1093-7. PubMed ID: 17251409
[TBL] [Abstract][Full Text] [Related]
11. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
12. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
13. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.
Schaaf HS; Victor TC; Engelke E; Brittle W; Marais BJ; Hesseling AC; van Helden PD; Donald PR
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):203-5. PubMed ID: 17294161
[TBL] [Abstract][Full Text] [Related]
14. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
[TBL] [Abstract][Full Text] [Related]
15. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis.
Cheng X; Zhang J; Yang L; Xu X; Liu J; Yu W; Su M; Hao X
J Microbiol Methods; 2007 Aug; 70(2):301-5. PubMed ID: 17543399
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
[TBL] [Abstract][Full Text] [Related]
17. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
Miotto P; Piana F; Penati V; Canducci F; Migliori GB; Cirillo DM
J Clin Microbiol; 2006 Jul; 44(7):2485-91. PubMed ID: 16825369
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-tuberculosis activity in some folklore plants by radiometric BACTEC assay.
Gupta VK; Shukla C; Bisht GR; Saikia D; Kumar S; Thakur RL
Lett Appl Microbiol; 2011 Jan; 52(1):33-40. PubMed ID: 21114505
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
Piddock LJ; Williams KJ; Ricci V
J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
[TBL] [Abstract][Full Text] [Related]
20. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes.
Coban AY; Cekic Cihan C; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
J Chemother; 2006 Apr; 18(2):140-3. PubMed ID: 16736881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
